Location History:
- Aichi-ken, JP (2004 - 2005)
- Chita-gun, JP (2001 - 2013)
- Aichi, JP (2003 - 2021)
Company Filing History:
11 out of 4,455 
10 out of 44 
1 out of 2,538 Years Active: 2001-2024
Title: Kiyoshi Kawamura: Pioneer in Heterocyclic and Biaryloxy Derivative Inventions
Introduction: Kiyoshi Kawamura is a prolific inventor based in Aichi, Japan, with an impressive portfolio of 22 patents. His work primarily focuses on novel pharmaceutical compounds that target specific ion channels involved in various health conditions.
Latest Patents: Kawamura's recent innovations include groundbreaking patents on heterocyclic derivatives serving as blockers for Nav1.7 and Nav1.8 voltage-gated sodium channels. These compounds are critical for the treatment and prevention of disorders and diseases associated with these channels. His other notable patent involves biaryloxy derivatives that act as blockers for TTX-S channels, offering further therapeutic options for related health issues. Both inventions emphasize the development of pharmaceutical compositions that leverage these compounds for medical applications.
Career Highlights: Throughout his career, Kawamura has contributed to major advancements in pharmaceuticals. He has been associated with Pfizer Corporation and Raqualia Pharma Inc., where his expertise in drug development has significantly influenced the industry.
Collaborations: Kawamura has collaborated with esteemed colleagues such as Mikio Morita and Chikara Uchida. Their collective efforts have led to innovative solutions in the realm of drug development, fostering an environment of creativity and scientific exploration.
Conclusion: Kiyoshi Kawamura stands out as a key figure in the field of pharmaceutical inventions, particularly in the area of sodium channel blockers. His continued innovation and collaboration with leading professionals highlight his commitment to advancing medical science and creating effective treatments for various disorders.